PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.
Also known as: Sermorelin & GHRP-6, Sermorelin + GHRP-6 Blend
A research blend combining the GHRH analog Sermorelin with the ghrelin-receptor agonist GHRP-6. It is studied for synergistic growth hormone release and appetite stimulation.
Sign in to rate this peptide.
Sermorelin (GHRH 1-29) activates the pituitary GHRH receptor to drive growth hormone synthesis and release. GHRP-6 is a hexapeptide agonist of the GHS-R1a (ghrelin) receptor that evokes a separate GH pulse, reduces somatostatin inhibition, and strongly stimulates appetite. The two compounds engage distinct receptor pathways, producing a synergistic amplification of pulsatile GH secretion while maintaining physiologic feedback control.